Skip to main content
. Author manuscript; available in PMC: 2021 Mar 13.
Published in final edited form as: ACS Infect Dis. 2020 Jan 13;6(3):467–478. doi: 10.1021/acsinfecdis.9b00406

Figure 6. LC-MS/MS bioanalytical studies of CysK-mediated false product formation.

Figure 6.

(A) The putative false product reaction mediated by CysK between OALS and compound 1 and LC-MS/MS spectra of E. coli cell extracts after treatment of compound 1 showing LC-MS/MS profile for (B) compound 1 and (C) the predicted false product (12) are shown.